UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Better therapeutic trials in ovarian cancer

JNCI : Journal of the National Cancer Institute, 2014-04, Vol.106 (4), p.dju029-dju029

2014

Volltextzugriff (PDF)

Chemosensitivity assays: still eyeing the clinic

JNCI : Journal of the National Cancer Institute, 2012-12, Vol.104 (23), p.1775-1777

Jenks, Susan

2012

Volltextzugriff (PDF)

Realistic Rodents? Debate Grows Over New Mouse Models of Cancer

JNCI : Journal of the National Cancer Institute, 2006-09, Vol.98 (17), p.1176-1178

Garber, Ken

2006

Volltextzugriff (PDF)

Dose Escalation Methods in Phase I Cancer Clinical Trials

JNCI : Journal of the National Cancer Institute, 2009-05, Vol.101 (10), p.708-720

2009

Volltextzugriff (PDF)

Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression

JNCI : Journal of the National Cancer Institute, 2016-10, Vol.108 (10), p.djw122

2016

Volltextzugriff (PDF)

TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3

Carcinogenesis (New York), 2016-11, Vol.37 (11), p.1041-1051

2016

Volltextzugriff (PDF)

Synergistic Highly Potent Targeted Drug Combinations in Different Pheochromocytoma Models Including Human Tumor Cultures

Endocrinology (Philadelphia), 2019-11, Vol.160 (11), p.2600-2617

2019

Volltextzugriff (PDF)

Antihistamines and Ovarian Cancer Survival: Nationwide Cohort Study and in Vitro Cell Viability Assay

JNCI : Journal of the National Cancer Institute, 2020-09, Vol.112 (9), p.964-967

2020

Volltextzugriff (PDF)

Lung Cancer Cell Lines as Tools for Biomedical Discovery and Research

JNCI : Journal of the National Cancer Institute, 2010-09, Vol.102 (17), p.1310-1321

2010

Volltextzugriff (PDF)

Distinct Cytotoxic Mechanisms of Pristine versus Hydroxylated Fullerene

Toxicological sciences, 2006-05, Vol.91 (1), p.173-183

2006

Volltextzugriff (PDF)

Prevention of prostate cancer by natural product MDM2 inhibitor GS25: in vitro and in vivo activities and molecular mechanisms

Carcinogenesis (New York), 2018-07, Vol.39 (8), p.1026-1036

2018

Volltextzugriff (PDF)

Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability

Carcinogenesis (New York), 2014-09, Vol.35 (9), p.1951-1961

2014

Volltextzugriff (PDF)

Fucoidan suppresses the gastric cancer cell malignant phenotype and production of TGF-β1 via CLEC-2

Glycobiology (Oxford), 2020-04, Vol.30 (5), p.301-311

2020

Volltextzugriff (PDF)

Antitumor properties of a new non-anticoagulant heparin analog from the mollusk Nodipecten nodosus: Effect on P-selectin, heparanase, metastasis and cellular recruitment

Glycobiology (Oxford), 2015-04, Vol.25 (4), p.386-393

2015

Volltextzugriff (PDF)

Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice

Glycobiology (Oxford), 2012-03, Vol.22 (3), p.400-410

2012

Volltextzugriff (PDF)

Tissue specificity of in vitro drug sensitivity

Journal of the American Medical Informatics Association : JAMIA, 2018-02, Vol.25 (2), p.158-166

2018

Volltextzugriff (PDF)

Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells

Carcinogenesis (New York), 2014-01, Vol.35 (1), p.192-200

2014

Volltextzugriff (PDF)

A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling

Carcinogenesis (New York), 2015-03, Vol.36 (3), p.318-326

2015

Volltextzugriff (PDF)

Dual targeting of MDM2 with a novel small-molecule inhibitor overcomes TRAIL resistance in cancer

Carcinogenesis (New York), 2016-11, Vol.37 (11), p.1027-1040

2016

Volltextzugriff (PDF)

Quantitative High-Throughput Drug Screening Identifies Novel Classes of Drugs with Anticancer Activity in Thyroid Cancer Cells: Opportunities for Repurposing

The journal of clinical endocrinology and metabolism, 2012-03, Vol.97 (3), p.E319-E328

2012

Volltextzugriff (PDF)

Flavonoids from each of the six structural groups reactivate BRM, a possible cofactor for the anticancer effects of flavonoids

Carcinogenesis (New York), 2014-10, Vol.35 (10), p.2183-2193

2014

Volltextzugriff (PDF)

Androgen deprivation induces phenotypic plasticity and promotes resistance to molecular targeted therapy in a PTEN-deficient mouse model of prostate cancer

Carcinogenesis (New York), 2014-09, Vol.35 (9), p.2142-2153

2014

Volltextzugriff (PDF)

Inhibition of hyaluronic acid formation sensitizes chronic myelogenous leukemia to treatment with doxorubicin

Glycobiology (Oxford), 2016-11, Vol.26 (11), p.1171-1179

2016

Volltextzugriff (PDF)

Effects of Deguelin on the Phosphatidylinositol 3-Kinase/Akt Pathway and Apoptosis in Premalignant Human Bronchial Epithelial Cells

JNCI : Journal of the National Cancer Institute, 2003-02, Vol.95 (4), p.291-302

2003

Volltextzugriff (PDF)

Oligosaccharide G19 inhibits U-87 MG human glioma cells growth in vitro and in vivo by targeting epidermal growth factor (EGF) and activating p53/p21 signaling

Glycobiology (Oxford), 2014-08, Vol.24 (8), p.748-765

2014

Volltextzugriff (PDF)

1 – 25 von 118

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

KollektionOxford Journals 2020 Medicine

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(118)

Publikationsform

Artikel
(118)

Sprache

Englisch
(118)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(106)
Science & Technology
(106)
Drug Screening Assays, Antitumor
(77)
Oncology
(77)
Animals
(47)
Biological And Medical Sciences
(47)
Antineoplastic Agents - Pharmacology
(46)
Medical Sciences
(46)
Mice
(34)
Tumor Cells, Cultured
(33)
Drug Screening Assays, Antitumor - Methods
(32)
Female
(31)
Tumors
(30)
Cell Line, Tumor
(28)
Antineoplastic Agents
(26)
Pharmacology. Drug Treatments
(25)
Antineoplastic Agents - Therapeutic Use
(19)
Cancer
(18)
Apoptosis - Drug Effects
(17)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Better therapeutic trials in ovarian cancer

Chemosensitivity assays: still eyeing the clinic

Realistic Rodents? Debate Grows Over New Mouse Models of Cancer

Dose Escalation Methods in Phase I Cancer Clinical Trials

Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression

TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3

Synergistic Highly Potent Targeted Drug Combinations in Different Pheochromocytoma Models Including Human Tumor Cultures

Antihistamines and Ovarian Cancer Survival: Nationwide Cohort Study and in Vitro Cell Viability Assay

Lung Cancer Cell Lines as Tools for Biomedical Discovery and Research

Distinct Cytotoxic Mechanisms of Pristine versus Hydroxylated Fullerene

Prevention of prostate cancer by natural product MDM2 inhibitor GS25: in vitro and in vivo activities and molecular mechanisms

Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability

Fucoidan suppresses the gastric cancer cell malignant phenotype and production of TGF-β1 via CLEC-2

Antitumor properties of a new non-anticoagulant heparin analog from the mollusk Nodipecten nodosus: Effect on P-selectin, heparanase, metastasis and cellular recruitment

Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice

Tissue specificity of in vitro drug sensitivity

Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells

A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling

Dual targeting of MDM2 with a novel small-molecule inhibitor overcomes TRAIL resistance in cancer

Quantitative High-Throughput Drug Screening Identifies Novel Classes of Drugs with Anticancer Activity in Thyroid Cancer Cells: Opportunities for Repurposing

Flavonoids from each of the six structural groups reactivate BRM, a possible cofactor for the anticancer effects of flavonoids

Androgen deprivation induces phenotypic plasticity and promotes resistance to molecular targeted therapy in a PTEN-deficient mouse model of prostate cancer

Inhibition of hyaluronic acid formation sensitizes chronic myelogenous leukemia to treatment with doxorubicin

Effects of Deguelin on the Phosphatidylinositol 3-Kinase/Akt Pathway and Apoptosis in Premalignant Human Bronchial Epithelial Cells

Oligosaccharide G19 inhibits U-87 MG human glioma cells growth in vitro and in vivo by targeting epidermal growth factor (EGF) and activating p53/p21 signaling

Aktive Filter

Suchergebnisse filtern